Cargando…
Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up
BACKGROUND: While circulating tumor cells may serve as minimally invasive cancer markers for bladder cancers, the relationship between primary bladder cancers and circulating tumor cells in terms of somatic mutations is largely unknown. Genome sequencing of bladder tumor and circulating tumor cells...
Autores principales: | Kim, Tae-Min, Yoo, Jin-seon, Moon, Hyong Woo, Hur, Kyung Jae, Choi, Jin Bong, Hong, Sung-Hoo, Lee, Ji Youl, Ha, U-Syn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720586/ https://www.ncbi.nlm.nih.gov/pubmed/33287735 http://dx.doi.org/10.1186/s12885-020-07684-6 |
Ejemplares similares
-
Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patients
por: Kim, Tae-Jung, et al.
Publicado: (2019) -
Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
por: Guo, Qiaomei, et al.
Publicado: (2018) -
The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
por: Mishima, Yuji, et al.
Publicado: (2017) -
Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer
por: Carrasco, Raquel, et al.
Publicado: (2022) -
Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
por: Ge, Zhouhong, et al.
Publicado: (2021)